Guangzhou RiboBio Co., Ltd. (RiboBio), headquartered in the Development Zone of Huangpu District, Guangzhou City, China is a biotech company specializing in nucleic acid technologies and providing products and technical services for non-coding RNA and cellular biology research. We’re committed to realizing the commercialization of next-generation oligonucleotide-based drugs. RiboBio is one of the leading enterprises in China’s nucleic acid industry and a key high-tech enterprise of the National Torch Program with a national postdoctoral scientific research workstation.
Founded by distinguished expert of the National Thousand Talents Program and 2006 Nobel Prize winner, RiboBio is working on basic life science and medical research with its global vision and technical strengths. We provide high-quality nucleic acid molecular and cellular biologic reagents, high-end scientific research services, as well as CDMO for oligonucleotide-based drugs. Our products and services have won the trust of both domestic and international customers with the integrated advantage of cross-disciplinary multi-platform between supply and demand.
With high-quality products and services, we serve more than 5,000 institutions at home and abroad and have been cited in more than 11,000 SCI papers. Our customers range from Nobel Prize winners’ laboratories to renowned research institutions and global pharmaceutical companies.
RiboBio is one of the well-known manufacturers of Oligonucleotide APIs in the industry. In 2016, we obtained China’s first CFDA-issued production license for Oligonucleotide APIs, ranking in the top oligonucleotide CDMO/CMO brands in the world. RiboBio has built a large-scale cGMP manufacturing workshop, and is currently working on the globe-leading Oligonucleotides CMO base.
We strive to promote the exchange and cooperation between science and technology worldwide by hosting the China Nucleic Acid Forum (CNAF) and the Conference of Non-coding RNA and Epigenetics (NCREC). We have been approved to establish a national postdoctoral research station, and have undertaken a number of national, provincial and municipal key scientific research projects.
We’re committed to building a world-class biotech company in products, services, platforms and partnership as well as innovative talents with an aim to contribute to the future advances of life science and medical transformation.
RiboBio holds a strong belief of “never stop innovating” to develop through innovation, to sustain growth with quality and to win customers with integrity.
Integrity, Pragmatism, High Efficiency & Mutual Benefit
Innovation, Learning, Respect & Excellence
Always improving human health and promoting nucleic acid science research
Building a world-leading biotech company in products, services, platforms, partnership and innovative talents.
Qualifications and Honors
RiboBio has gained wide recognition and praise from customers with its leading products and services since establishment. RiboBio’s honors include Key High-tech Enterprise of China Torch Progra, Key Entrepreneur Team of Overseas Chinese by the Overseas Chinese Affairs Office of the State Council, High-tech Enterprise of Guangdong Province, Enterprise Technology Center of Guangdong Province, Innovative Research Team Introduced by Guangdong Province, High-Tech Product of Guangdong Province, Gazelle Business of Guangzhou Development District, etc.. RiboBio was appointed to establish Industry-Academia-Research Consortium for the Translational Medicine with Nanfang Hospital, Guangzhou Postdoctoral Innovation Practice Base and National Postdoctoral Workstation. It is under ISO13485 and ISO9001 management system, and has also obtained the certification of A-class Management Enterprise of the Customs.
Guangdong Pearl River Talent Program
Key High-tech Enterprise of China Torch Program
High-tech Enterprise of Guangdong Province
Innovative Research Team Introduced by Guangdong Province
Guangzhou Postdoctoral Innovation Practice Base and National Postdoctoral Workstation
Intellectual Property Advantage Enterprise
Key Entrepreneur Team of Overseas Chinese by the Overseas Chinese Affairs Office of the State Council
RiboBio has participated in and accomplished projects of National High Technology Research and Development Plan, the National 863 Program, the Key New Drug Development Program of the State’s 12th Five-Year Plan, as well as several key scientific projects of Guangzhou and Guangdong Province. The researches on non-coding ribonucleic acid (miRNA, piRNA, circRNA and lncRNA) and gene silencing technology have achieved 17 authorized patents, of which 3 are international patents.
National Postdoctoral Workstation
Oligonucleotide-based Drugs Engineering Technology Research Center
Enterprise Research and Development Institution
National Genetic Testing Technology Demonstration Center
Industry-Academia-Research Consortium for the Translational Medicine
Overseas Chinese Contribution Award